Search research articles
Contact Us
Filters
Showing results (291-300 of 304) with videos related to
Page
of 31
Sort By:
British Journal of Cancer
|
November 11, 2010
LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
R Matsuda, H Enokida, T Chiyomaru, et al.
The Journal of Biological Chemistry
|
January 24, 1997
Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein
T S Kim, C S Sundaresh, S I Feinstein, et al.
Cancer Research
|
May 30, 1998
Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2
T Hishiki, Y Nimura, E Isogai, et al.
Medical and Pediatric Oncology
|
July 24, 2001
Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas
S Ichimiya, Y Nimura, H Kageyama, et al.
International Journal of Oncology
|
April 14, 2000
Identification of the full-length KIAA0591 gene encoding a novel kinesin-related protein which is mapped to the neuroblastoma suppressor gene locus at 1p36.2
M Nagai, S Ichimiya, T Ozaki, et al.
Journal of Medicinal Chemistry
|
February 15, 2001
Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography
M Orita, S Yamamoto, N Katayama, et al.
Arthritis and Rheumatism
|
January 1, 2000
Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes
Y Date, N Seki, S Kamizono, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study
K Suzuki, T Yamanaka, H Hashimoto, et al.
Journal of Epidemiology
|
October 3, 2001
Validity and reliability of single-item questions about physical activity
N Iwai, S Hisamichi, N Hayakawa, et al.
Medical and Pediatric Oncology
|
December 7, 2000
Identification of the homozygously deleted region at chromosome 1p36.2 in human neuroblastoma
A Nakagawara, M Ohira, H Kageyama, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 304) with videos related to
Sort By:
Page
of 31
British Journal of Cancer
|
November 11, 2010
LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
R Matsuda, H Enokida, T Chiyomaru, et al.
The Journal of Biological Chemistry
|
January 24, 1997
Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein
T S Kim, C S Sundaresh, S I Feinstein, et al.
Cancer Research
|
May 30, 1998
Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2
T Hishiki, Y Nimura, E Isogai, et al.
Medical and Pediatric Oncology
|
July 24, 2001
Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas
S Ichimiya, Y Nimura, H Kageyama, et al.
International Journal of Oncology
|
April 14, 2000
Identification of the full-length KIAA0591 gene encoding a novel kinesin-related protein which is mapped to the neuroblastoma suppressor gene locus at 1p36.2
M Nagai, S Ichimiya, T Ozaki, et al.
Journal of Medicinal Chemistry
|
February 15, 2001
Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography
M Orita, S Yamamoto, N Katayama, et al.
Arthritis and Rheumatism
|
January 1, 2000
Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes
Y Date, N Seki, S Kamizono, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study
K Suzuki, T Yamanaka, H Hashimoto, et al.
Journal of Epidemiology
|
October 3, 2001
Validity and reliability of single-item questions about physical activity
N Iwai, S Hisamichi, N Hayakawa, et al.
Medical and Pediatric Oncology
|
December 7, 2000
Identification of the homozygously deleted region at chromosome 1p36.2 in human neuroblastoma
A Nakagawara, M Ohira, H Kageyama, et al.
Page
of 31